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Résumé en
anglais
BACKGROUND: Pseudoxanthoma elasticum (PXE), caused by mutations in the ABCC6
gene, is a rare multiorgan disease characterized by the mineralization and
fragmentation of elastic fibers in connective tissue. Cardiac complications reportedly
associated with PXE are mainly based on case reports. METHODS: A cohort of 67 PXE
patients was prospectively assessed. Patients underwent physical examination,
electrocardiogram, transthoracic echocardiography, cardiac magnetic resonance
imaging (CMR), treadmill testing, and perfusion myocardial scintigraphy (SPECT).
Additionally, the hearts of a PXE mouse models (Abcc6(-/-)) and wild-type controls
(WT) were analyzed. RESULTS: Three patients had a history of proven coronary artery
disease. In total, 40 patients underwent exercise treadmill tests, and 28 SPECT. The
treadmill tests were all negative. SPECT showed mild perfusion abnormalities in two
patients. Mean left ventricular (LV) dimension and function values were within the
normal range. LV hypertrophy was found in 7 (10.4%) patients, though the
hypertrophy etiology was unknown for 3 of those patients. Echocardiography revealed
frequent but insignificant mitral and tricuspid valvulopathies. Mitral valve prolapse
was present in 3 patients (4.5%). Two patients exhibited significant aortic stenosis
(3.0%). While none of the functional and histological parameters diverged significantly
between the Abcc6(-/-) and WT mice groups at age of 6 and 12 months, the 24-month-
old Abcc6(-/-) mice developed cardiac hypertrophy without contractile dysfunction.
CONCLUSIONS: Despite sporadic cases, PXE does not appear to be associated with
frequent cardiac complications. However, the development of cardiac hypertrophy in
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